Literature DB >> 2022159

Control of gastric pH with ranitidine in critically ill patients. Comparison of two intravenous regimens.

L Santucci1, S Fiorucci, M A Pelli, A Calderazzo, E Biasini, P L Calderazzo, A Morelli.   

Abstract

The effects of continuous versus bolus administration of ranitidine on gastric pH were compared in critically ill patients admitted to our intensive care unit. Patients were randomized to receive 0.2 mg/kg/hr ranitidine in continuous infusion or 50 mg in bolus every 4 hr. The pH was monitored throughout a 24-hr period, 2 hr in basal conditions and 22 hr during treatment, with a gastric probe. Basal gastric pH was 2.1 +/- 0.2 in the infused and 2.4 +/- 0.2 in the bolus group (P greater than 0.05). The hydrogen ion concentrations were 25.1 +/- 8 and 20.0 +/- 7 mmol/liter, respectively (P greater than 0.05). After ranitidine administration, mean pH was 6.3 +/- 0.6 in patients treated by infusion and 4.5 +/- 0.5 (P less than 0.001) in those who received the drug in bolus; hydrogen ion concentration was 2.5 +/- 2 and 6.9 +/- 6, respectively, (P less than 0.001). Percent of inhibition of acid secretion was 90% in the infused and 68% in the bolus group. Infusion raised pH to values constantly above 4, whereas bolus administration resulted in wide fluctuations. These data indicate that continuous infusion of ranitidine is superior to bolus administration in controlling gastric acidity in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022159     DOI: 10.1007/bf01297023

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

Review 1.  Pathogenesis of experimental gastric-mucosal injury.

Authors:  E Kivilaakso; W Silen
Journal:  N Engl J Med       Date:  1979-08-16       Impact factor: 91.245

2.  Prevention of acute stress bleeding with sucralfate, antacids, or cimetidine. A controlled study with pirenzepine as a basic medication.

Authors:  M Tryba; F Zevounou; M Torok; M Zenz
Journal:  Am J Med       Date:  1985-08-30       Impact factor: 4.965

3.  Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill.

Authors:  J C Stothert; D A Simonowitz; E P Dellinger; M Farley; W A Edwards; A D Blair; R Cutler; C J Carrico
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

4.  Acute gastroduodenal lesions related to severe sepsis.

Authors:  J R Le Gall; F C Mignon; M Rapin; M Redjemi; A Harari; J P Bader; C J Soussy
Journal:  Surg Gynecol Obstet       Date:  1976-03

5.  Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury.

Authors:  H P McElwee; K R Sirinek; B A Levine
Journal:  Surgery       Date:  1979-10       Impact factor: 3.982

6.  Cimetidine versus antacids in the prevention of stress erosions in critically ill patients.

Authors:  M H Poleski; A H Spanier
Journal:  Am J Gastroenterol       Date:  1986-02       Impact factor: 10.864

7.  Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit.

Authors:  D A Peura; L F Johnson
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

8.  Cimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients. Controlled, randomized trial.

Authors:  N Basso; M Bagarani; A Materia; S Fiorani; P Lunardi; V Speranza
Journal:  Am J Surg       Date:  1981-03       Impact factor: 2.565

9.  Predictive value of intramural pH and other risk factors for massive bleeding from stress ulceration.

Authors:  R G Fiddian-Green; E McGough; G Pittenger; E Rothman
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

10.  Antacid versus sucralfate in preventing acute gastrointestinal bleeding. A randomized trial in 100 critically ill patients.

Authors:  E Borrero; I B Margolis; S Bank; N Shulman; R Chardavoyne
Journal:  Am J Surg       Date:  1984-12       Impact factor: 2.565

View more
  6 in total

1.  Twenty-four-hour intragastric pH patterns in ICU patients on ranitidine.

Authors:  J G Moore; T P Clemmer; S Taylor; A L Bishop; S Maggio
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

Review 2.  Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.

Authors:  J Nash; L Lambert; M Deakin
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

3.  Control of gastric pH with ranitidine in patients with Crohn's disease receiving total parenteral nutrition. Comparison of two intravenous regimens.

Authors:  T Matsui; A Motomura; M Arita; Y Takeyama; T Sakurai; T Yao
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

4.  Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects.

Authors:  S Teyssen; S T Chari; J Scheid; M V Singer
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

5.  Pattern of 72-hour intragastric acidity in a homogeneous group of intensive care unit patients.

Authors:  W P Geus; S J Smith; J A De Haas; C B Lamers
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

6.  [Concept of stress ulcer prevention. Is re-thinking necessary?].

Authors:  S Kress; D Schilling; J F Riemann
Journal:  Med Klin (Munich)       Date:  1998-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.